Company Filing History:
Years Active: 2013
Title: Mahindra Makhija: Innovator in Histone Deacetylase Inhibitors
Introduction
Mahindra Makhija is a notable inventor based in Ghatkopar, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that serve as histone deacetylase inhibitors. His work is crucial in the ongoing research for effective treatments in various diseases.
Latest Patents
Makhija holds a patent for "Tetrahydro-fused pyridines as histone deacetylase inhibitors." This patent describes compounds of formula (I), wherein ring D and ring E together form a fused ring system selected from formulas (II), (III), (IV), (V), (VI), and (VII). The salts of these compounds are recognized as novel and effective inhibitors of histone deacetylases, which play a vital role in gene regulation and cancer therapy.
Career Highlights
Makhija is currently associated with 4SC AG, a company that focuses on the development of innovative therapies for cancer and autoimmune diseases. His expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Some of his notable coworkers include Thomas Maier and Thomas Beckers, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Mahindra Makhija's work in developing histone deacetylase inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the treatment of various diseases.